5CU2:
reference: A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066., De Fusco C, Brear P, Iegre J, Georgiou KH, Sore HF, Hyvonen M, Spring DR, Bioorg Med Chem. 2017 Apr 30. pii: S0968-0896(16)31479-1. doi:, 10.1016/j.bmc.2017.04.037. PMID: 28495381

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).